» Articles » PMID: 35783102

Glial Cells and Brain Diseases: Inflammasomes As Relevant Pathological Entities

Overview
Specialty Cell Biology
Date 2022 Jul 5
PMID 35783102
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammation mediated by the innate immune system is a physiopathological response to diverse detrimental circumstances such as microbe infections or tissular damage. The molecular events that underlie this response involve the assembly of multiprotein complexes known as inflammasomes. These assemblages are essentially formed by a stressor-sensing protein, an adapter protein and a non-apoptotic caspase (1 or 11). The coordinated aggregation of these components mediates the processing and release of pro-inflammatory interleukins (IL-β and IL-18) and cellular death by pyroptosis induction. The inflammatory response is essential for the defense of the organism; for example, it triggers tissue repair and the destruction of pathogen microbe infections. However, when inflammation is activated chronically, it promotes diverse pathologies in the lung, liver, brain and other organs. The nervous system is one of the main tissues where the inflammatory process has been characterized, and its implications in health and disease are starting to be understood. Thus, the regulation of inflammasomes in specific cellular types of the central nervous system needs to be thoroughly understood to innovate treatments for diverse pathologies. In this review, the presence and participation of inflammasomes in pathological conditions in different types of glial cells will be discussed.

Citing Articles

3-Dimensional morphological characterization of neuroretinal microglia in Alzheimer's disease via machine learning.

Nassrallah W, Li H, Irani L, Wijesinghe P, Hogg P, Hui L Acta Neuropathol Commun. 2024; 12(1):202.

PMID: 39719599 PMC: 11669245. DOI: 10.1186/s40478-024-01898-6.


Research progress in the mechanism of acupuncture regulating microglia in the treatment of Alzheimer's disease.

Liu J, Zhou J, You C, Xia H, Gao Y, Liu Y Front Neurosci. 2024; 18:1435082.

PMID: 39145293 PMC: 11321967. DOI: 10.3389/fnins.2024.1435082.


Microglia as a Possible Alternative Therapeutic for Dementia.

Alavez-Rubio J, Juarez-Cedillo T J Alzheimers Dis Rep. 2024; 8(1):43-56.

PMID: 38229830 PMC: 10789290. DOI: 10.3233/ADR-230112.


Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease.

Terzioglu G, Young-Pearse T Mol Neurodegener. 2023; 18(1):89.

PMID: 38017562 PMC: 10685641. DOI: 10.1186/s13024-023-00674-9.


Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases.

Han T, Xu Y, Sun L, Hashimoto M, Wei J Neural Regen Res. 2023; 19(6):1241-1248.

PMID: 37905870 PMC: 11467914. DOI: 10.4103/1673-5374.385845.


References
1.
Wu P, Hung Y, Liu H, Hsueh Y . Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model. Neuroimmunomodulation. 2017; 24(1):29-39. DOI: 10.1159/000477092. View

2.
Fann D, Lee S, Manzanero S, Chunduri P, Sobey C, Arumugam T . Pathogenesis of acute stroke and the role of inflammasomes. Ageing Res Rev. 2013; 12(4):941-66. DOI: 10.1016/j.arr.2013.09.004. View

3.
Maier A, Deigendesch N, Muller K, Weishaupt J, Krannich A, Rohle R . Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis--A Pilot Study. PLoS One. 2015; 10(10):e0139684. PMC: 4596620. DOI: 10.1371/journal.pone.0139684. View

4.
Zhang H, Yu S, Xia L, Peng X, Wang S, Yao B . NLRP3 Inflammasome Activation Enhances ADK Expression to Accelerate Epilepsy in Mice. Neurochem Res. 2021; 47(3):713-722. DOI: 10.1007/s11064-021-03479-8. View

5.
Zhou Y, Lu M, Du R, Qiao C, Jiang C, Zhang K . MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease. Mol Neurodegener. 2016; 11:28. PMC: 4833896. DOI: 10.1186/s13024-016-0094-3. View